Snapshot from Aug 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Kimberly-Clark cuts forecasts on...
Business earnings guidance

Kimberly-Clark cuts forecasts on China diaper claims

Analysis based on 8 articles · First reported Aug 04, 2026 · Last updated Aug 04, 2026

Sentiment
-30
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

Kimberly-Clark's shares were volatile in early trading as the company cut its annual forecasts, reflecting investor concerns about the China disruption and its impact on growth. The guidance cut may also affect sentiment toward the broader consumer staples sector, though the impact is largely company-specific.

Consumer goods Personal care
Event Summary

Kimberly-Clark cut its annual sales and profit forecasts on August 4, 2026, citing a significant hit to second-quarter sales in China from false social media claims that its Huggies diapers contained toxic formamide. The company refuted the claims with independent testing by a government-certified third party, but the disruption is expected to continue pressuring sales and profit in the near term. China's market regulator launched a joint investigation on June 22 without naming any brand and has not provided an update. The company now expects 2026 organic sales growth to trail category growth by about 100 basis points, and adjusted EPS growth at a high-single-digit rate, down from double-digit. The China disruption is expected to reduce International Personal Care organic growth by 3-4 percentage points and operating profit growth by 10-12 percentage points. Net sales rose 0.6% to $4.19 billion, slightly below estimates, while adjusted operating profit rose 6.2% to $757 million. The company is also progressing on its $40 billion acquisition of Kenvue and recently finalized the sale of a 51% stake in its international tissue business to Suzano Papel e Celulose, creating the Arbex joint venture.

Key Actions
90 Kimberly-Clark cut forecasts
70 China launched investigation
60 Kimberly-Clark refuted claims
50 Kimberly-Clark finalized sale Suzano Papel e Celulose
40 Kimberly-Clark reported earnings
Entities Involved
stock
Kimberly-Clark
Kimberly-Clark is the central company, cutting its annual forecasts due to the China diaper claims and facing near-term sales and profit pressure. The company is defending its franchise and progressing on strategic moves like the Kenvue acquisition and Arbex JV.
Importance 100.0 Sentiment -40.0
cnt
China
China is the key market where the false claims originated, causing significant sales disruption for Kimberly-Clark. The regulator's investigation and consumer sentiment are central to the event.
Importance 80.0 Sentiment -20.0
stock
Kenvue
Kenvue is the target of Kimberly-Clark's roughly $40 billion acquisition, expected to close by year-end. The acquisition is part of Kimberly-Clark's strategy, though the China disruption may affect the deal's timing or financing.
Importance 30.0 Sentiment 10.0
per
Mike Hsu
Mike Hsu is the CEO of Kimberly-Clark, expressing confidence in product quality and acknowledging the need to work through the China issue. His leadership is under scrutiny.
Importance 30.0 Sentiment -10.0
stock
Suzano Papel e Celulose
Suzano Papel e Celulose acquired a 51% stake in Kimberly-Clark's international tissue business, forming the Arbex joint venture. This deal is separate from the China issue and strengthens Suzano Papel e Celulose's position in the tissue market.
Importance 25.0 Sentiment 20.0
per
Russ Torres
Russ Torres is the COO, labeling the China disruption a 'one-time external impact' and outlining the expected financial impact on the International Personal Care segment.
Importance 25.0 Sentiment -10.0
cnt
United States
The United States is a major market where Kimberly-Clark saw a slight volume decline due to inflation and consumer spending cuts. This adds to the company's challenges.
Importance 20.0 Sentiment -10.0
priv
Child care
Child care is a Chinese diaper brand that reportedly tested positive for formamide, contributing to the controversy. It faces reputational damage and potential regulatory scrutiny.
Importance 20.0 Sentiment -20.0
priv
Bibabebe
Bibabebe is another Chinese diaper brand reportedly testing positive for formamide, similarly affected by the controversy and regulatory investigation.
Importance 20.0 Sentiment -20.0
stock
Procter & Gamble
Procter & Gamble is a competitor in the diaper and personal care market. The China disruption may indirectly benefit P&G if consumers switch brands, though no direct impact is mentioned.
Importance 15.0 Sentiment 10.0
stock
Essity
Essity is a competitor in the tissue and personal care market. Similar to P&G, it may see indirect benefits from Kimberly-Clark's China troubles, but no direct impact is detailed.
Importance 15.0 Sentiment 10.0
per
Brian Mulroney
Brian Mulroney is a market strategist at Zacks Investment Management, commenting on the potential prolonged reputational issue delaying market share recovery. His view reflects analyst sentiment.
Importance 10.0 Sentiment -5.0
priv
Zacks Investment Management
Zacks Investment Management is an investment firm whose strategist provided commentary on the event, indicating market analyst perspective.
Importance 10.0 Sentiment -5.0
stock
London Stock Exchange Group
London Stock Exchange Group provided analyst consensus data for Kimberly-Clark's earnings, used to compare actual results. It is a data provider, not directly affected.
Importance 5.0 Sentiment 0.0
priv
Hong Kong Free Press
Hong Kong Free Press is a media outlet that reported on the formamide claims, contributing to the spread of the story. It is not directly affected financially.
Importance 5.0 Sentiment 0.0
+ 1 more entities View on Dashboard
Relationships
China strategic rivals ↔ United States China views the United States as a strategic rival, characterized by ongoing trade disputes, technological competition,
Kenvue related ↔ United States
United States related ↔ Procter & Gamble
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.